Pathological significance of ganglioside clusters in Alzheimer's disease

Journal of Neurochemistry

Volumn 116, Issue 5, 2011, Pages 806-812

  Yanagisawa, Katsuhiko ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Alzheimer's disease; amyloid protein; cholesterol; ganglioside; lipid raft; sphingomyelin

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; CHOLESTEROL; GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GM3; LIPOSOME; RAB PROTEIN; SPHINGOMYELIN;

AGING; ALPHA HELIX; ALZHEIMER DISEASE; ATOMIC FORCE MICROSCOPY; BINDING AFFINITY; CLUSTER ANALYSIS; CONFORMATIONAL TRANSITION; ENDOCYTOSIS; HYDROPHOBICITY; IMMUNOREACTIVITY; LIPID COMPOSITION; LIPID RAFT; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SYNAPTOSOME;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CELL MEMBRANE; GANGLIOSIDES; HUMANS; MICROSCOPY, ATOMIC FORCE; PROTEIN BINDING;

EID: 79851485651     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07006.x     Document Type: Review

References (42)

1. Ariga T., Kobayashi K., Hasegawa A., Kiso M., Ishida H., and, Miyatake T., (2001) Characterization of high-affinity binding between gangliosides and amyloid β-protein. Arch. Biochem. Biophys. 388, 225-230. (Pubitemid 32911613)
2. Ariga T., McDonald M. P., and, Yu R. K., (2008) Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease - a review. J. Lipid Res. 49, 1157-1175.
3. Ariga T., Miyatake T., and, Yu R. K., (2010) Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies-a review. J. Neurosci. Res. 88, 2303-2315.
4. Bugiani O., Giaccone G., Verga L., Pollo B., Ghetti B., Frangione B., and, Tagliavini F., (1990) Alzheimer patients and Down patients: abnormal presynaptic terminals are related to cerebral preamyloid deposits. Neurosci. Lett. 119, 56-59. (Pubitemid 20349726)
5. Cataldo A. M., Peterhoff C. M., Troncoso J. C., Gomez-Isla T., Hyman B. T., and, Nixon R. A., (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157, 277-286. (Pubitemid 30641743)
6. Choo-Smith L. P., and, Surewicz W. K., (1997a) The interaction between Alzheimer amyloid β (1-40) peptide and ganglioside GM1-containing membranes. FEBS Lett. 402, 95-98. (Pubitemid 27078236)
7. Choo-Smith L. P., Garzon-Rodriguez W., Glabe C. G., and, Surewicz W. K., (1997b) Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272, 22987-22990. (Pubitemid 27392420)
8. Grimm M. O. W., Grimm H. S., Paetzold A. J., et al. (2005) Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin. Nat. Cell Biol. 7, 1118-1123.
9. Grimm M. O. W., Tschaepe J.-A., Grimm H. S., Zinser E. G., and, Hartmann T., (2006) Altered membrane fluidity and lipid raft composition in presenilin-deficient cells. Acta Neurol. Scand. 114, 27-32. (Pubitemid 44015222)
10. Gylys K. H., Fein J. A., Yang F., Miller C. A., and, Cole G. M., (2007) Increased cholesterol in Aβ-positive nerve terminals from Alzheimer's disease cortex. Neurobiol. Aging 28, 8-17. (Pubitemid 44791634)
11. Hayashi H., Kimura N., Yamaguchi H., et al. (2004) A seed for Alzheimer amyloid in the brain. J. Neurosci. 24, 4894-4902. (Pubitemid 38668215)
12. Kakio A., Nishimoto S. I., Yanagisawa K., Kozutsumi Y., and, Matsuzaki K., (2001) Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276, 24985-24990.
13. Kakio A., Nishimoto S. I., Yanagisawa K., Kozutsumi Y., and, Matsuzaki K., (2002) Interactions of amyloid β-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41, 7385-7390. (Pubitemid 34602456)
14. Kimura N., and, Yanagisawa K., (2007) Endosomal accumulation of GM1 ganglioside-bound amyloid β-protein in neurons of aged monkey brains. Neuroreport. 18, 1669-1673. (Pubitemid 47549131)
15. Kiyokawa K., Baba T., Otsuka N., Makino A., Ohno S., and, Kobayashi T., (2005) Spatial and functional heterogeneity of sphingolipid-rich membrane domains. J. Biol. Chem. 280, 24072-24084. (Pubitemid 40884895)
16. Mao Y., Zhiguo S., Imai Y., Hoshino T., Tero R., Tanaka M., Yamamoto N., Yanagisawa K., and, Urisu T., (2010) Surface-induced phase separation of sphingomyelin/cholesterol/ganglioside GM1-planar bilayer on mica surfaces and microdomain molecular conformation that accelerates Aβ oligomerization. Biochim. Biophys. Acta 1798, 1090-1099.
17. Matsuzaki K., and, Horikiri C., (1999) Interactions of amyloid β-peptide (1-40) with ganglioside-containing membranes. Biochemistry 38, 4137-4142.
18. Matsuzaki K., Kato K., and, Yanagisawa K., (2010) Aβ polymerization through interaction with membrane gangliosides. Biochim. Biophys. Acta 1801, 868-877.
19. McLaurin J., and, Chakrabartty A., (1996) Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity. J. Biol. Chem. 271, 26482-26489. (Pubitemid 26359045)
20. Molander-Melin M., Blennow K., Bogdanovic N., Dellheden B., Mansson J. E., and, Fredman P., (2005) Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains. J. Neurochem. 92, 171-182. (Pubitemid 40193519)
21. Nguyen H. N., Son D. J., Lee J. W., et al. (2006) Mutant presenilin 2 causes abnormality in the brain lipid profile in the development of Alzheimer's disease. Arch. Pharm. Res. 29, 884-889.
22. Parton R. G., (1994) Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J. Histochem. Cytochem. 42, 155-166. (Pubitemid 24042232)
23. Probst A., Langui D., Ipsen S., Robakis N., and, Ulrich J., (1991) Deposition of β/A4 protein along neuronal plasma membranes in diffuse senile plaques. Acta Neuropathol. 83, 21-29.
24. Sperling R. A., LaViolette P. S., O'Keefe K., et al. (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63, 178-188.
25. Tamboli I. Y., Prager K., Thal D. R., et al. (2008) Loss of Îí-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis. J. Neurosci. 28, 12097-12106.
26. Utsumi M., Yamaguchi Y., Sasakawa H., Yamamoto N., Yanagisawa K., and, Kato K., (2009) Up-and-down topological mode of amyloid β-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters. Glycoconjugate J. 26, 999-1006.
27. Williamson M. P., Suzuki Y., Bourne N. T., and, Asakura T., (2006) Binding of amyloid β-peptide to ganglioside micelles is dependent on histidine-13. Biochem. J. 397, 483-490. (Pubitemid 44187506)
28. Woolf N. J., Jacobs R. W., and, Butcher L. L., (1989) The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease. Neurosci. Lett. 96, 277-282. (Pubitemid 19026693)
29. Yagi-Utsumi M., Kameda T., Yamaguchi Y., and, Kato K., (2010) NMR characterization of the interaction between lyso-GM1 aqueous micelles and amyloid β. FEBS Lett. 584, 831-836.
30. Yahi N., Aulas A., and, Fantini J., (2010) How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's β amyloid peptide (Aβ1-40). PLoS ONE 5, e9079.
31. Yamamoto N., Igbabvoa U., Shimada Y., Ohno-Iwashita Y., Kobayashi M., Wood W. G., Fujita S. C., and, Yanagisawa K., (2004) Accelerated Aβ aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain. FEBS Lett. 569, 135-139. (Pubitemid 38844606)
32. Yamamoto N., Yokoseki T., Shibata M., Yamaguchi H., and, Yanagisawa K., (2005a) Suppression of Aβ deposition in brain by peripheral administration of Fab fragments of anti-seed antibody. Biochem. Biophys. Res. Commun. 335, 45-47. (Pubitemid 41350761)
33. Yamamoto N., Hirabayashi Y., Amari M., Yamaguchi H., Romanov G., Van Nostrand W. E., and, Yanagisawa K., (2005b) Assembly of hereditary amyloid β-protein variants in the presence of favorable gangliosides. FEBS Lett. 579, 2185-2190. (Pubitemid 40469690)
34. Yamamoto N., Van Nostrand W. E., and, Yanagisawa K., (2006) Further evidence of local ganglioside-dependent amyloid β-protein assembly in brain. Neuroreport 17, 1735-1737. (Pubitemid 44621574)
35. Yamamoto N., Matsubara E., Maeda S., Minagawa H., Takashima A., Maruyama W., Michikawa M., and, Yanagisawa K., (2007) A ganglioside-induced toxic soluble Aβ assembly: its enhanced formation from Aβ bearing the Arctic mutation. J. Biol. Chem. 282, 2646-2655. (Pubitemid 47076773)
36. Yamamoto N., Matsubara T., Sato T., and, Yanagisawa K., (2008) Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloidβ-protein fibrillogenesis. Biochim. Biophys. Acta 1778, 2717-2726.
37. Yanagisawa K., (2007) Role of gangliosides in Alzheimer's disease. Biochim. Biophys. Acta 1768, 1943-1951. (Pubitemid 47125848)
38. Yanagisawa K., Odaka A., Suzuki N., and, Ihara Y., (1995) GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1, 1062-1066.
39. Yuyama K., and, Yanagisawa K., (2009) Late endocytic dysfunction as a putative cause of amyloid fibril formation in Alzheimer's disease. J. Neurochem. 109, 1250-1260.
40. Yuyama K., and, Yanagisawa K., (2010) Sphingomyelin accumulation provides favorable milieu for GM1 ganglioside-induced assembly of amyloid β-proteins. Neurosci. Lett. 481, 168-172.
41. Yuyama K., Yamamoto N., and, Yanagisawa K., (2006) Chloroquine-induced endocytic pathway abnormalities: cellular model of GM1 ganglioside-induced Aβ fibrillogenesis in Alzheimer's disease. FEBS Lett. 580, 6972-6976. (Pubitemid 44909146)
42. Yuyama K., Yamamoto N., and, Yanagisawa K., (2008) Accelerated release of exosome-associated GM1 ganglioside (GM1) by endocytic pathway abnormality: another putative pathway for GM1-induced amyloid fibril formation. J. Neurochem. 105, 217-224. (Pubitemid 351441638)